FUJIFILM Biotechnologies introduces ShunzymeX precision purification technology for downstream processing of complex biologics: Teessid, United Kingdom Thursday, March 5, 2026, 16 ...
Fujifilm Biotechnologies is unveiling a precision purification tool, ShunzymeX, that simplifies downstream processing for ...
ShunzymeX addresses inherent challenges in traditional microbial downstream purification due to microbial-expressed protein diversity.
FUJIFILM Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today unveils ShunzymeX precision purification ...
FUJIFILM Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today unveils ShunzymeX precision purification ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 11:10 AM ESTCompany ParticipantsUdit Batra - President, CEO ...
From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.
Discover strategies to overcome sample preparation challenges in clinical proteomics, optimizing workflows for researchers.
Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development ...
Together, these findings indicate that astrocytes undergo profound sex- and region-specific adaptations to chronic ethanol, implicating extracellular matrix and glycosaminoglycan remodeling as key ...
Power Metallic Mines Inc. (the "Company" or "Power Metallic") is pleased to provide an exploration update of recent drilling ...
The rise of nitazenes, highly addictive opioids, needs advanced detection methods to match. Innovative biosensors may be central in helping to address this public health crisis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results